We often hold it to be self-evident that antibodies are key to an effective immune response against a pathogen—the more (or more potent) antibodies your body makes, the better it will fight off an ...

In a recent study posted to the bioRxiv* server, researchers reported that some monoclonal neutralizing antibodies (nAbs) directed against distinct receptor-binding domain (RBD) epitopes nested inside ...

Researchers have shown that infections with two different common human coronaviruses (HCoVs) don't generate antibodies that effectively cross-react with SARS-CoV-2. So, prior infection with HCoVs is ...

Vaccines against coronavirus disease 2019 (COVID-19) developed and produced during the COVID-19 pandemic offer a significant degree of protection. However, after the second dose of a vaccine, ...

A recent study published in PLOS ONE investigated whether antibodies enhance severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Study: Anti-SARS-CoV-2 IgG and IgA antibodies in ...

After 75 years of global efforts to find a vaccine to fight dengue, virologists are suggesting that inoculation may not offer long-lasting immunity against all four dengue virus serotypes. Lack of a ...

The venom from Bothrops Asper, a Costa Rican lancehead snake, can cause debilitating damage to muscle tissue. Photo: Vanesa Zarzosa. What makes a soldier switch sides? That is a really good question.

Although SARS-CoV-2 has taken the world by storm, it’s not the only coronavirus that can infect humans. But unlike SARS-CoV-2, common human coronaviruses (HCoVs) generally cause only mild disease. Now ...

A promising antibody failed testing. This is good news for developing a broad-spectrum antidote against the world's most dangerous snake venoms. What makes a soldier switch sides? That is a really ...